Exchange: NASDAQ·Updated 07:51 PM EDT

ALGN News

News
all
press releases
This HubSpot Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Analysts downgraded HubSpot, Group 1 Automotive, Align Technology, AutoNation and more, cutting ratings and price targets.read more...
Benzinga
This HubSpot Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Analysts downgraded HubSpot, Group 1 Automotive, Align Technology, AutoNation and more, cutting ratings and price targets.read more...
Benzinga
More News
Will Align Technology (ALGN) Beat Estimates Again in Its Next Earnings Report?
Align Technology (ALGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks
Align Technology to Announce Third Quarter 2026 Results on October 28, 2026
Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report...
Business Wire
Here's What Might Affect CVS Health's 2026 Financial Outlook
CVS raises its 2026 revenue and earnings outlook, but reimbursement pressure, macro headwinds and soft front-store demand could weigh on results.
Zacks
Should You Continue to Hold ALGN Stock in Your Portfolio?
Align Technology expands Invisalign and digital dentistry adoption as iTero gains traction, but weak capital spending and currency volatility remain risks.
Zacks
Align Technology to Speak at Upcoming Financial Conference
Align Technology, Inc. (Align) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the...
Business Wire
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.
Zacks
Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?
Technology is becoming a bigger part of CAH's strategy, linking distribution, specialty services and logistics through digital workflows.
Zacks
Here's How CVS Is Focusing on Aetna's Profitability Turnaround
CVS Health is advancing Aetna's profitability turnaround, supported by stronger Health Care Benefits results, an improved MBR and operational initiatives.
Zacks
Here's How CVS' Improving Balance Sheet Supports Deleveraging
CVS Health's strong cash generation, higher operating cash flow outlook and disciplined capital deployment support continued deleveraging in 2026.
Zacks

Advertisement|Remove ads.